the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

MADA, other agencies ordered to resolve issue of padi seed price – Mohamad

KUALA LUMPUR: The Ministry of Agriculture and Food Security has directed several agencies and manufacturers of legal padi seeds (BPS) to immediately resolve complaints related to the delay in the supply and sales of BPS which exceeded the price set by the government.

Its minister Datuk Seri Mohamad Sabu said the agencies include the Muda Agricultural Development Authority (MADA), the Padi and Rice Regulatory Board, the Department of Agriculture and Regional Farmers’ Organisation (PPK).

He said the directive was issued following complaints from several farmers and padi farmers’ organisations on the issue, so that he went to the field to conduct monitoring and inspection yesterday (Nov 14) at two factories that hold permits to produce BPS in Kedah.

“The results of the inspection have identified several issues causing BPS supply disruptions now.

“The BPS manufacturer has also given a commitment to supply BPS with immediate effect to MADA. “For areas outside MADA’s supervision, I have ordered inspections and enforcement to be enhanced,“ he said in a statement here today.

Mohamad said strict action must be taken against any party that fails to comply with the instructions to sell padi seed at RM45 per 20 kilogramme bag.

He hopes that all parties involved will cooperate so that all arising issues can be resolved immediately to ensure that the rice planting process can comply with the schedule that has been set. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings